Individuals who are over 45 years old, are overweight or obese, have experienced gestational diabetes during pregnancy, or have high blood pressure are also at a higher risk of developing prediabetes and Type 2 diabetes
Secondary analyses of the MAESTRO-NASH trial suggest that resmetirom retains efficacy in patients concomitantly using GLP-1 RAs, supporting the feasibility of combination approaches [71]
doi: 10.2337/diabetes.53.8.2095
Side Effects and Tolerability Differences Both medications work by slowing digestion and reducing appetite, so nausea, constipation, and mild diarrhea are common early side effects with either choice
Revolutionary Medications 15 % Weight loss over a year The new, smarter way to lose weight Enter your current weight (lbs): How much you could lose (lbs): 14 lbs lose Semaglutide (the active ingredient in Ozempic and Wegovy) is a GLP-1 medication that may be prescribed for weight loss, if appropriate
To learn more about digestive side effects, check out our guide on Ozempic digestive side effects